Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications
Zezhi Li, Meihua Ruan, Jun Chen, et al.
Neuroscience Bulletin (2021) Vol. 37, Iss. 6, pp. 863-880
Open Access | Times Cited: 242

Showing 1-25 of 242 citing articles:

Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation?
Stefan Harsanyi, Ida Kupcová, Ľuboš Danišovič, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 578-578
Open Access | Times Cited: 130
Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder
Andrew J. Cutler, Gregory W. Mattingly, Vladimir Maletic
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 60
BDNF Unveiled: Exploring Its Role in Major Depression Disorder Serotonergic Imbalance and Associated Stress Conditions
Ana Salomé Correia, Armando Cardoso, Nuno Vale
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2081-2081
Open Access | Times Cited: 48
Impacts of microbiota and its metabolites through gut-brain axis on pathophysiology of major depressive disorder
Cong-Ya Chen, Yufei Wang, Lan Lei, et al.
Life Sciences (2024) Vol. 351, pp. 122815-122815
Closed Access | Times Cited: 19
The molecular pathophysiology of depression and the new therapeutics
Haihua Tian, Zhenyu Hu, Jia Xu, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 64
Targeting neuroinflammation by polyphenols: A promising therapeutic approach against inflammation-associated depression
Mohammed Abu Tayab, Mohammad Nazmul Islam, Kazi Ashfak Ahmed Chowdhury, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112668-112668
Open Access | Times Cited: 62
Possible antidepressant mechanisms of omega-3 polyunsaturated fatty acids acting on the central nervous system
Lie Zhou, Jiayao Xiong, Yu-Qian Chai, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 50
In vitro modeling of the human dopaminergic system using spatially arranged ventral midbrain–striatum–cortex assembloids
Daniel Reumann, Christian Krauditsch, Maria Novatchkova, et al.
Nature Methods (2023) Vol. 20, Iss. 12, pp. 2034-2047
Open Access | Times Cited: 35
A Comprehensive Overview of the Role of Visual Cortex Malfunction in Depressive Disorders: Opportunities and Challenges
Fangfang Wu, Qing-Bo Lu, Yan Kong, et al.
Neuroscience Bulletin (2023) Vol. 39, Iss. 9, pp. 1426-1438
Open Access | Times Cited: 31
Connecting Dots between Mitochondrial Dysfunction and Depression
Mehtab Khan, Yann Baussan, Étienne Hébert-Chatelain
Biomolecules (2023) Vol. 13, Iss. 4, pp. 695-695
Open Access | Times Cited: 27
Combining Glial Fibrillary Acidic Protein and Neurofilament Light Chain for the Diagnosis of Major Depressive Disorder
JinXia Zhang, Dan Liu, Juan Xiang, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 4, pp. 1693-1699
Closed Access | Times Cited: 9
Early Life Stress and Major Depressive Disorder—An Update on Molecular Mechanisms and Synaptic Impairments
Amanda Gollo Bertollo, Agatha Carina Leite Galvan, Claudia Dallagnol, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 9, pp. 6469-6483
Closed Access | Times Cited: 9
The chronic unpredictable mild stress (CUMS) Paradigm: Bridging the gap in depression research from bench to bedside
Shweta Sharma, Shivani Chawla, Praveen Kumar, et al.
Brain Research (2024) Vol. 1843, pp. 149123-149123
Closed Access | Times Cited: 9
Advancements Exploring Major Depressive Disorder: Insights on Oxidative Stress, Serotonin Metabolism, BDNF, HPA Axis Dysfunction, and Pharmacotherapy Advances
Ana Salomé Correia, Nuno Vale
International Journal of Translational Medicine (2024) Vol. 4, Iss. 1, pp. 176-196
Open Access | Times Cited: 8
Major Depressive Disorder: Existing Hypotheses about Pathophysiological Mechanisms and New Genetic Findings
Muhammad Kamran, Farhana Bibi, Asim ur Rehman, et al.
Genes (2022) Vol. 13, Iss. 4, pp. 646-646
Open Access | Times Cited: 36
Ketamine as a therapeutic agent in major depressive disorder and posttraumatic stress disorder: Potential medicinal and deleterious effects
Bhuvi Sachdeva, Punya Sachdeva, Shampa Ghosh, et al.
Ibrain (2023) Vol. 9, Iss. 1, pp. 90-101
Open Access | Times Cited: 19
Prevalence and associated factors of binge eating disorder among Bahraini youth and young adults: a cross-sectional study in a self-selected convenience sample
Zahraa A. Rasool Abbas Abdulla, Hend Omar Almahmood, Razan Raed Alghasra, et al.
Journal of Eating Disorders (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 18
Mitochondrial Metabolism in Major Depressive Disorder: From Early Diagnosis to Emerging Treatment Options
Ane Larrea, Laura Sánchez-Sánchez, Eguzkiñe Díez-Martín, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1727-1727
Open Access | Times Cited: 7
Omega-3 fatty acids and major depression: a Mendelian randomization study
Rebecca Carnegie, Maria Carolina Borges, Hannah Jones, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
The role of microglia heterogeneity in synaptic plasticity and brain disorders: Will sequencing shed light on the discovery of new therapeutic targets?
Yi You, Zhong Chen, Weiwei Hu
Pharmacology & Therapeutics (2024) Vol. 255, pp. 108606-108606
Closed Access | Times Cited: 5
Relationship of depression and sleep quality, diseases and general characteristics
Yan Jiang, Tao Jiang, Litao Xu, et al.
World Journal of Psychiatry (2022) Vol. 12, Iss. 5, pp. 722-738
Open Access | Times Cited: 26
Structural and functional features of treatment‐resistant depression: A systematic review and exploratory coordinate‐based meta‐analysis of neuroimaging studies
Alessandro Miola, Nicola Meda, Giulia Perini, et al.
Psychiatry and Clinical Neurosciences (2023) Vol. 77, Iss. 5, pp. 252-263
Open Access | Times Cited: 15
Motor cortical plasticity as a predictor of treatment response to high frequency repetitive transcranial magnetic stimulation (rTMS) for cognitive function in drug-naive patients with major depressive disorder
Xingxing Li, Chang Yu, Yan Ding, et al.
Journal of Affective Disorders (2023) Vol. 334, pp. 180-186
Closed Access | Times Cited: 13
Unraveling the Role of the Blood-Brain Barrier in the Pathophysiology of Depression: Recent Advances and Future Perspectives
Shamili Mariya Varghese, Shashikant Patel, Amritasree Nandan, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 12, pp. 10398-10447
Closed Access | Times Cited: 5
Exploring adverse events of Vilazodone: evidence from the FAERS database
Ying Jiang, Yucai Qu, Zhiqiang Du, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top